Creatine for Depressed Male and Female Methamphetamine Users

Part of paid clinical trials in Missoula, Montana.

Sponsor
Montana State University
Study ID
NCT02568878
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 59 Years
Healthy Volunteers
Not accepted

Interventions

  • Creatine monohydrate — DRUG

Study Details

* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression

Key Dates

Start date
Nov 30, 2015
Status verified
Dec 2015
Primary completion
Oct 31, 2016
Completion
May 31, 2017

Study Design

Enrollment
29 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Creatine monohydrate
    5 grams of daily creatine monohydrate by mouth for 8 weeks

Primary Outcome Measure

Hamilton Depression Rating Scale (HAMD) Scores [ Time Frame: This data will be assessed after 12 participants have completed the study and again after a completed sample size of 24 is achieved. The data will be presented at study completion (anticipated: 12 months after study initiation). ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Montana State University College of Nursing (Missoula campus)MissoulaMontana59812
Tracy Hellem, PhD
[email protected]
406-243-2110
4062432110
Tracy Hellem, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Missoula, MT

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Montana State University College of Nursing (Missoula campus)· Missoula, MT

Related Studies